Cerebral Hemorrhage Due to Autonomic Dysreflexia in a Spinal Cord Injury Patient

Overview

Journal Spinal Cord

Specialty Neurology

Date 2005 Jul 13

PMID 16010281

Citations 20

Authors

M Valles

J Benito

E Portell

J Vidal

Affiliations

Soon will be listed here.

Abstract

Study Design: Case report.

Objective: To report an uncommon case of cerebral hemorrhage due to autonomic dysreflexia (AD) in a spinal cord injury (SCI) patient.

Setting: Institut Guttmann, Neurorehabilitation Hospital in Barcelona, Spain.

Case Report: An SCI patient developed AD due to urinary tract infection after surgery for a pressure sore. The hypertension was difficult to control and the case progressed to hypertensive encephalopathy. MRI of the brain was performed showing a hemorrhagic lesion on the left occipital area. The hypertension was finally controlled and the neurological status improved although with some cognitive deficits.

Conclusion: This is an uncommon case of cerebral hemorrhage due to AD, showing the importance of an adequate diagnosis and treatment of AD to avoid this life-threatening complication.

Citing Articles

Dysreflexic dilemma: do we need a revised definition for autonomic dysreflexia?.

Sober-Williams E, Lucci V, McBride C, Willms R, Solinsky R, Mathias C Clin Auton Res. 2024; .

PMID: 39572481 DOI: 10.1007/s10286-024-01078-5.

Autonomic dysreflexia in patients with cancer and spinal cord injury: a case series.

Qin E, Marshall G, Ruppert L Spinal Cord Ser Cases. 2024; 10(1):66.

PMID: 39231946 PMC: 11375159. DOI: 10.1038/s41394-024-00678-7.

Autonomic Dysreflexia in Spinal Cord Injury: Mechanisms and Prospective Therapeutic Targets.

Trueblood C, Singh A, Cusimano M, Hou S Neuroscientist. 2023; 30(5):597-611.

PMID: 38084412 PMC: 11166887. DOI: 10.1177/10738584231217455.

Autonomic dysreflexia: Current pharmacologic management.

Solinsky R PM R. 2023; 15(12):1519-1523.

PMID: 37545115 PMC: 10841367. DOI: 10.1002/pmrj.13051.

Treating Neurogenic Lower Urinary Tract Dysfunction in Chronic Spinal Cord Injury Patients-When Intravesical Botox Injection or Urethral Botox Injection Are Indicated.

Chen P, Lee K, Lee W, Yeh T, Kuo Y, Chiang B Toxins (Basel). 2023; 15(4).

PMID: 37104226 PMC: 10145925. DOI: 10.3390/toxins15040288.